Sp1/Sp3 transcription factors regulate hallmarks of megakaryocyte maturation and platelet formation and function

M Meinders, Divine Kulu, Harmen van de Werken, M Hoogenboezem, H Janssen, Rutger Brouwer, Wilfred van Ijcken, HWJ Rijkers, Jeroen Demmers, I Kruger, TK van den Berg, G Suske, L Gutierrez, Sjaak Philipsen

Research output: Contribution to journalArticleAcademicpeer-review

54 Citations (Scopus)

Abstract

Sp1 and Sp3 belong to the specificity proteins (Sp)/Kruppel-like transcription factor family. They are closely related, ubiquitously expressed, and recognize G-rich DNA motifs. They are thought to regulate generic processes such as cell-cycle and growth control, metabolic pathways, and apoptosis. Ablation of Sp1 or Sp3 in mice is lethal, and combined haploinsufficiency results in hematopoietic defects during the fetal stages. Here, we show that in adult mice, conditional pan-hematopoietic (Mx1-Cre) ablation of either Sp1 or Sp3 has minimal impact on hematopoiesis, whereas the simultaneous loss of Sp1 and Sp3 results in severe macrothrombocytopenia. This occurs in a cell-autonomous manner as shown by megakaryocyte-specific (Pf4-Cre) double-knockout mice. We employed flow cytometry, cell culture, and electron microscopy and show that although megakaryocyte numbers are normal in bone marrow and spleen, they display a less compact demarcation membrane system and a striking inability to form proplatelets. Through megakaryocyte transcriptomics and platelet proteomics, we identified several cytoskeleton-related proteins and downstream effector kinases, including Mylk, that were downregulated upon Sp1/Sp3 depletion, providing an explanation for the observed defects in megakaryopoiesis. Supporting this notion, selective Mylk inhibition by ML7 affected proplatelet formation and stabilization and resulted in defective ITAM receptor-mediated platelet aggregation.
Original languageUndefined/Unknown
Pages (from-to)1957-1967
Number of pages11
JournalBlood
Volume125
Issue number12
DOIs
Publication statusPublished - 2015

Research programs

  • EMC MGC-02-13-02
  • EMC MGC-02-21-01

Cite this